2011
DOI: 10.1186/1472-6874-11-31
|View full text |Cite
|
Sign up to set email alerts
|

Symptom interpretation and health care seeking in ovarian cancer

Abstract: BackgroundOvarian cancer is the leading cause of death among women suffering from gynaecological malignancies in the Western world. Worldwide, approximately 200,000 women are diagnosed with the disease each year. This article deals with the health care seeking and symptom interpretation process among Danish women, who have a very high mortality rate.MethodsThe health seeking and symptom interpretation process was analysed via combining study methods. The material consisted of registry data dealing with the use… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
36
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(38 citation statements)
references
References 28 publications
0
36
1
Order By: Relevance
“…Despite this and the moderate knowledge of the symptoms of ovarian cancer, delays in diagnosis occur frequently (Cooper et al, 2013;Evans et al, 2007;Koldjeski et al, 2004;Seibaek et al, 2011). Despite this and the moderate knowledge of the symptoms of ovarian cancer, delays in diagnosis occur frequently (Cooper et al, 2013;Evans et al, 2007;Koldjeski et al, 2004;Seibaek et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Despite this and the moderate knowledge of the symptoms of ovarian cancer, delays in diagnosis occur frequently (Cooper et al, 2013;Evans et al, 2007;Koldjeski et al, 2004;Seibaek et al, 2011). Despite this and the moderate knowledge of the symptoms of ovarian cancer, delays in diagnosis occur frequently (Cooper et al, 2013;Evans et al, 2007;Koldjeski et al, 2004;Seibaek et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…The clinical symptoms of ovarian cancer are vague and similar to those observed in other benign conditions; hence, the majority of patients are often diagnosed at a late stage which almost always translates into a poor prognosis (Seibaek et al, 2011). To date, there are a growing number of patients who present with a pelvic mass; therefore, it is necessary to identify the potential malignant ovarian disease DOI:http://dx.doi.org/10.7314/APJCP.2016.17.1.323 Tissue CA125 and HE4 Gene Expression Offers Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses risk as early as possible to improve clinical outcome and survival of patients (Kobayashi et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…Ovarian cancer has a major impact on health care, being the second most common malignancy in women, but is still the leading cause of death in females who have gynecological tumors in the Western world [1]. Although this tumor type may develop at young ages, the median patient age is 65 years; hence, the majority of the cases are postmenopausal women [2].…”
Section: Introductionmentioning
confidence: 99%